NASDAQ:ICCC
ImmuCell Corporation Stock News
$4.74
-0.0700 (-1.46%)
At Close: May 20, 2024
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript
01:48pm, Wednesday, 15'th May 2024
ImmuCell Corporation (NASDAQ:ICCC ) Q1 2024 Results Conference Call May 15, 2024 9:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President & CEO Conference Call Participan
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
04:05pm, Tuesday, 14'th May 2024
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
01:00pm, Wednesday, 08'th May 2024
PORTLAND, Maine, May 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
04:05pm, Tuesday, 09'th Apr 2024
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript
11:58am, Wednesday, 28'th Feb 2024
ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
04:05pm, Tuesday, 27'th Feb 2024
PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
09:30am, Friday, 16'th Feb 2024
Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
04:05pm, Monday, 08'th Jan 2024
PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) Q3 2023 Earnings Call Transcript
02:36pm, Tuesday, 14'th Nov 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q3 2023 Earnings Conference Call November 14, 2023 9:00 AM ET Company Participants Joe Diaz - Managing Partner; Lytham Partners, LLC Michael Brigham - CEO Conferenc
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
04:05pm, Monday, 13'th Nov 2023
PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
12:15pm, Tuesday, 07'th Nov 2023
Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
04:05pm, Thursday, 05'th Oct 2023
PORTLAND, Maine, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Submission of CMC Technical Section to the FDA
08:00am, Tuesday, 29'th Aug 2023
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript
04:48pm, Friday, 11'th Aug 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2023 Earnings Conference Call August 11, 2023 9:00 AM ET Company Participants Joe Dorame - Lytham Partners, IR Michael Brigham - President and Chief Executive Of
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
04:05pm, Thursday, 10'th Aug 2023
PORTLAND, Maine, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
